256 related articles for article (PubMed ID: 15731587)
1. Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american population.
Sambuughin N; Holley H; Muldoon S; Brandom BW; de Bantel AM; Tobin JR; Nelson TE; Goldfarb LG
Anesthesiology; 2005 Mar; 102(3):515-21. PubMed ID: 15731587
[TBL] [Abstract][Full Text] [Related]
2. Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing.
Ibarra M CA; Wu S; Murayama K; Minami N; Ichihara Y; Kikuchi H; Noguchi S; Hayashi YK; Ochiai R; Nishino I
Anesthesiology; 2006 Jun; 104(6):1146-54. PubMed ID: 16732084
[TBL] [Abstract][Full Text] [Related]
3. North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations.
Sambuughin N; Sei Y; Gallagher KL; Wyre HW; Madsen D; Nelson TE; Fletcher JE; Rosenberg H; Muldoon SM
Anesthesiology; 2001 Sep; 95(3):594-9. PubMed ID: 11575529
[TBL] [Abstract][Full Text] [Related]
4. Malignant hyperthermia in North America: genetic screening of the three hot spots in the type I ryanodine receptor gene.
Sei Y; Sambuughin NN; Davis EJ; Sachs D; Cuenca PB; Brandom BW; Tautz T; Rosenberg H; Nelson TE; Muldoon SM
Anesthesiology; 2004 Oct; 101(4):824-30. PubMed ID: 15448513
[TBL] [Abstract][Full Text] [Related]
5. Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.
Galli L; Orrico A; Lorenzini S; Censini S; Falciani M; Covacci A; Tegazzin V; Sorrentino V
Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835904
[TBL] [Abstract][Full Text] [Related]
6. Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations.
Rueffert H; Olthoff D; Deutrich C; Meinecke CD; Froster UG
Acta Anaesthesiol Scand; 2002 Jul; 46(6):692-8. PubMed ID: 12059893
[TBL] [Abstract][Full Text] [Related]
7. [Molecular genetic analysis of the ryanodine receptor gene (RYR1) in Korean malignant hyperthermia families].
Lee H; Kim DC; Lee JH; Cho YG; Lee HS; Choi SI; Kim DS
Korean J Lab Med; 2010 Dec; 30(6):702-10. PubMed ID: 21157159
[TBL] [Abstract][Full Text] [Related]
8. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
McCarthy TV; Quane KA; Lynch PJ
Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
[TBL] [Abstract][Full Text] [Related]
9. Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in a malignant hyperthermia family by sequencing of a leukocyte transcript.
Loke JC; Kraev N; Sharma P; Du G; Patel L; Kraev A; MacLennan DH
Anesthesiology; 2003 Aug; 99(2):297-302. PubMed ID: 12883402
[TBL] [Abstract][Full Text] [Related]
10. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1).
Roberts MC; Mickelson JR; Patterson EE; Nelson TE; Armstrong PJ; Brunson DB; Hogan K
Anesthesiology; 2001 Sep; 95(3):716-25. PubMed ID: 11575546
[TBL] [Abstract][Full Text] [Related]
11. Mutation screening of the RYR1-cDNA from peripheral B-lymphocytes in 15 Swedish malignant hyperthermia index cases.
Broman M; Gehrig A; Islander G; Bodelsson M; Ranklev-Twetman E; Rüffert H; Müller CR
Br J Anaesth; 2009 May; 102(5):642-9. PubMed ID: 19346234
[TBL] [Abstract][Full Text] [Related]
12. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
Ta TA; Pessah IN
Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of 2 known ryanodine receptor mutations causing malignant hyperthermia.
Schiemann AH; Paul N; Parker R; Pollock N; Bulger TF; Stowell KM
Anesth Analg; 2014 Feb; 118(2):375-380. PubMed ID: 24361844
[TBL] [Abstract][Full Text] [Related]
14. Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States.
Brandom BW; Bina S; Wong CA; Wallace T; Visoiu M; Isackson PJ; Vladutiu GD; Sambuughin N; Muldoon SM
Anesth Analg; 2013 May; 116(5):1078-1086. PubMed ID: 23558838
[TBL] [Abstract][Full Text] [Related]
15. Identification of malignant hyperthermia-susceptible ryanodine receptor type 1 gene (RYR1) mutations in a child who died in a car after exposure to a high environmental temperature.
Nishio H; Sato T; Fukunishi S; Tamura A; Iwata M; Tsuboi K; Suzuki K
Leg Med (Tokyo); 2009 May; 11(3):142-3. PubMed ID: 19223216
[TBL] [Abstract][Full Text] [Related]
16. Screening of the ryanodine 1 gene for malignant hyperthermia causative mutations by high resolution melt curve analysis.
Broman M; Heinecke K; Islander G; Schuster F; Glahn K; Bodelsson M; Treves S; Müller C
Anesth Analg; 2011 Nov; 113(5):1120-8. PubMed ID: 21965348
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in RYR1 and malignant hyperthermia phenotypes.
Carpenter D; Robinson RL; Quinnell RJ; Ringrose C; Hogg M; Casson F; Booms P; Iles DE; Halsall PJ; Steele DS; Shaw MA; Hopkins PM
Br J Anaesth; 2009 Oct; 103(4):538-48. PubMed ID: 19648156
[TBL] [Abstract][Full Text] [Related]
18. Novel skeletal muscle ryanodine receptor mutation in a large Brazilian family with malignant hyperthermia.
McWilliams S; Nelson T; Sudo RT; Zapata-Sudo G; Batti M; Sambuughin N
Clin Genet; 2002 Jul; 62(1):80-3. PubMed ID: 12123492
[TBL] [Abstract][Full Text] [Related]
19. Increasing the number of diagnostic mutations in malignant hyperthermia.
Levano S; Vukcevic M; Singer M; Matter A; Treves S; Urwyler A; Girard T
Hum Mutat; 2009 Apr; 30(4):590-8. PubMed ID: 19191329
[TBL] [Abstract][Full Text] [Related]
20. Reduced threshold for store overload-induced Ca
Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
